These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38690909)

  • 1. Optimizing treatment outcomes: integrating antihypertensive drug concentration measurement, personalized feedback, and psychosocial factors in resistant hypertension.
    Rubin D; Lo DF; Jammula S; Carroll N; Vasudevan M
    J Hypertens; 2024 Jun; 42(6):1105-1106. PubMed ID: 38690909
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to 'optimizing treatment outcomes: integrating antihypertensive drug concentration measurement, personalized feedback, and psychosocial factors in resistant hypertension'.
    Peeters LEJ; Koch BCP; Versmissen J
    J Hypertens; 2024 Jun; 42(6):1106-1107. PubMed ID: 38690910
    [No Abstract]   [Full Text] [Related]  

  • 3. Medication adherence and resistant hypertension.
    Hyman DJ; Pavlik V
    J Hum Hypertens; 2015 Apr; 29(4):213-8. PubMed ID: 25209307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of drug compliance in patients with high blood pressure resistant to antihypertensive therapy.
    Waeber B; Feihl F
    EuroIntervention; 2013 May; 9 Suppl R():R29-34. PubMed ID: 23732152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Woman With Treatment-Resistant Hypertension.
    Currie G; Delles C; Touyz RM; Staessen JA; Dominiczak AF; Jennings GL; Wang JG
    Hypertension; 2016 Feb; 67(2):243-50. PubMed ID: 26711735
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistant Hypertension: An Incurable Disease or Just a Challenge For Our Medical Skill?
    Di Pilla M; Bruno RM; Taddei S
    High Blood Press Cardiovasc Prev; 2016 Dec; 23(4):347-353. PubMed ID: 27188195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects.
    Kjeldsen SE; Os I; Mahfoud F
    EuroIntervention; 2013 May; 9 Suppl R():R7-9. PubMed ID: 23732159
    [No Abstract]   [Full Text] [Related]  

  • 8. Resistant Hypertension: An Update.
    Calhoun DA; Schiffrin EL; Flack JM
    Am J Hypertens; 2019 Jan; 32(1):1-3. PubMed ID: 30407514
    [No Abstract]   [Full Text] [Related]  

  • 9. Resistant hypertension in the elderly: optimizing outcomes while avoiding adverse effects.
    Strunk AD; Mayer SD
    Consult Pharm; 2013 May; 28(5):307-12. PubMed ID: 23649679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redefining Resistant Hypertension: A Comparison of Cardiovascular Risk Associated With the 2018 Versus 2008 American Heart Association Definitions for Resistant Hypertension.
    Smith SM; Gurka MJ; Winterstein AG; Handberg E; Pepine CJ; Cooper-DeHoff RM
    Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e005979. PubMed ID: 32008359
    [No Abstract]   [Full Text] [Related]  

  • 11. Summary and Conclusions.
    Bakris G
    High Blood Press Cardiovasc Prev; 2015 Jul; 22 Suppl 1():S23. PubMed ID: 26149526
    [No Abstract]   [Full Text] [Related]  

  • 12. Muscling in on Resistant Hypertension.
    Valenzuela PL; Ruilope LM; Lucia A
    Circulation; 2020 Jan; 141(4):240-242. PubMed ID: 31986090
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistant hypertension-complex mix of secondary causes and comorbidities.
    Dudenbostel T
    J Hum Hypertens; 2014 Jan; 28(1):1-2. PubMed ID: 23739161
    [No Abstract]   [Full Text] [Related]  

  • 14. If I had resistant hypertension.
    O'Brien E
    Hypertension; 2014 Nov; 64(5):e3-6. PubMed ID: 25113965
    [No Abstract]   [Full Text] [Related]  

  • 15. Managing Treatment-Resistant Patients.
    Schmieder RE
    High Blood Press Cardiovasc Prev; 2015 Jul; 22 Suppl 1():S11-3. PubMed ID: 26025221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistant hypertension and the neglected antihypertensive: sodium restriction.
    Agarwal R
    Nephrol Dial Transplant; 2012 Nov; 27(11):4041-5. PubMed ID: 22899870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
    Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistant systemic hypertension.
    Al-Baba B
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):340-2. PubMed ID: 21451335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different strategies from monotherapies to dual or triple fixed dose combination therapies to achieve blood pressure goals: a summary of a satellite symposium from the European Society of Hypertension.
    Volpe M
    High Blood Press Cardiovasc Prev; 2015 Jul; 22 Suppl 1():S1. PubMed ID: 26153400
    [No Abstract]   [Full Text] [Related]  

  • 20. Emerging Concepts in the Diagnosis and Treatment of Hypertension in the SPRINT Era.
    Phillips RA
    Methodist Debakey Cardiovasc J; 2015; 11(4):204-5. PubMed ID: 27057287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.